MedTrace Logo

Safety and Efficiency of Electrocautery-enhanced Lumen-apposing Stents - a Single Center Experience

NCT05210842 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-02-10

No results posted yet for this study

Summary

Lumen approximating stents have been used in interventional endoscopy to treat retentions in the upper gastrointestinal tract for 10 years. In the last few years, these have also been used with great success to form new anastomoses, especially in palliative patients. In this regard, many studies have been conducted in recent years.

As one of the largest centers for interventional endoscopy in Austria, we have been performing such interventions as standard since 2016.

The use of LAMS has become the standard therapy in many places. Most of the literature describes the technical advantages of LAMS, while the complications are less discussed. Although complications are rare with reported rates below 10%, with the multitude of technological and clinical advances in the field, it is important to understand and manage potential complications such as bleeding, perforation and stent migration.

Our goal is to evaluate the safety, efficacy, and outcome of all EC-LAMS in a single, high-volume center.

Method:

Suitable patients are analyzed retrospectively from the existing database. All patients who had a lumen-proximating stent implanted are included.

Conditions

  • Complication

Interventions

OTHER

Endoscopy

The procedures are performed using a flexible therapeutic linear array echoendoscope.

Sponsors & Collaborators

  • Salzburger Landeskliniken

    lead OTHER

Principal Investigators

  • Franz Singhartinger, Dr. · Salzburger Landeskliniken

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-28
Primary Completion
2022-02-28
Completion
2022-02-28

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05210842 on ClinicalTrials.gov